300858 科拓生物
2025/06 - 中期
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资22,276854.00%2,3352,0182,0162,431
投资性房地产0--0000
固定资产359,791-3.51%372,861207,055197,548201,229
在建工程298,86373.69%172,069156,65238,7393,492
无形资产54,92913.66%48,32651,05953,04554,158
商誉1,9130.00%1,9131,9131,9131,913
其他非流动资产173,371-52.29%363,388435,853171,43124,915
911,143-5.18%960,893854,550464,692288,139

流动资产
货币资金62,560-42.41%108,635191,596875,358481,823
应收账款69,07322.31%56,47465,395103,266115,087
存货44,074-5.42%46,59939,22350,93352,848
其他流动资产856,74215.31%742,996659,337297,428102,832
1,032,4498.14%954,705955,5511,326,986752,590

流动负债
短期借款0--0000
应付票据0--0000
应付帐款48,9402.54%47,72816,06136,44827,350
其他流动负债75,20855.19%48,46142,57748,83335,125
124,14829.07%96,18958,63885,28162,475
流动资产净值908,3025.80%858,516896,9131,241,705690,115
资产总额减流动负债1,819,4440.00%1,819,4091,751,4631,706,397978,254

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债28,196-5.51%29,84118,4629,82910,858
28,196-5.51%29,84118,4629,82910,858

总权益
    实收股本263,4950.00%263,495263,495175,663148,532
    储备项目1,527,7530.11%1,526,0731,469,5061,520,905818,865
股东权益1,791,2490.09%1,789,5681,733,0011,696,568967,397
非控股权益0--0000